Host: Pam R. Taub, MD, FACC, FASPC Guest: Steven Yakubov, MD, MSCAI, FACC The Changing TAVR Landscape" is a comprehensive multiepisodic CME series addressing critical aspects of the evolving transcatheter aortic valve replacement (TAVR) land

Host: Richard S. Isaacson, MD Guest: Pierre N. Tariot, MD Guest: Gayatri Devi, MD, MS, FAAN, FACP Alzheimer’s Disease (AD) has historically been a condition associated with more questions than answers. These questions are only increasing

Host: Richard S. Isaacson, MD Guest: Pierre N. Tariot, MD Guest: Gayatri Devi, MD, MS, FAAN, FACP Alzheimer’s Disease (AD) has historically been a condition associated with more questions than answers. These questions are only increasing

Host: Richard S. Isaacson, MD Guest: Pierre N. Tariot, MD Guest: Gayatri Devi, MD, MS, FAAN, FACP Alzheimer’s Disease (AD) has historically been a condition associated with more questions than answers. These questions are only increasing

Host: Richard S. Isaacson, MD Guest: Pierre N. Tariot, MD Guest: Gayatri Devi, MD, MS, FAAN, FACP Alzheimer’s Disease (AD) has historically been a condition associated with more questions than answers. These questions are only increasing

Host: Clete A. Kushida, MD, PhD Guest: Michael J. Thorpy, MD Three different sodium oxybate formulations are available for the management of narcolepsy with/without cataplexy. While they are equally efficacious, there are differences such as

Host: Michael J. Thorpy, MD Guest: Anne Marie Morse, DO Half of children who develop narcolepsy do so before age 16. However, the majority do not get diagnosed in childhood. In fact, many children are misdiagnosed and, as a result, are medic

Guest: Prem Soman, MD, PhD, MASNC Guest: Sarah Cuddy, MD Guest: Angela Dispenzieri, MD Host: Saurabh Malhotra, MD, MPH Guest: Sharmila Dorbala, MD, MPH, FASNC Guest: Yvonne Eisele, PhD Guest: Mazan Hanna, MD Guest: Isabelle Lou

Guest: Caron A. Jacobson, MD CD19-directed chimeric antigen receptor (CAR) T-cell therapies are revolutionizing the treatment of aggressive non-Hodgkin lymphoma (NHL), offering patients with refractory/relapsed disease the chance for a potential

Host: William T. Abraham, MD, FACP, FACC, FAHA, FESC, FRCPE Guest: Georges Chahoud, MD, FACC, FAHA, FHFSA, FASE Guest: Patrick J. McCann, MD Even with guideline-directed medical therapy, or GDMT, many patients with heart failure are limi